{
  "zip": "1105 BP",
  "sector": "",
  "fullTimeEmployees": 170,
  "longBusinessSummary": "Kiadis Pharma N.V., a biopharmaceutical company, develops cell-based immunotherapy products in the field of blood building system. The company develops K-NK002 as an adjunctive immunotherapeutic, which is in Phase II clinical trials for blood cancer patients undergoing a haploidentical HSCT with the post-transplant cyclophosphamide (PTCy) protocol; and K-NK003, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia relapse/refractory (AML R/R). The company's preclinical stage product include K-NK00X, a NK-cell therapy candidate for the treatment of various solid tumors. It has a collaboration agreement with Harbour BioMed, Utrecht University, Erasmus Medical Center, and Viroclinics-DDL for the development of a combination of a monoclonal antibody and natural killer cells as a treatment for COVID-19. Kiadis Pharma N.V. was founded in 1997 and is headquartered in Amsterdam, the Netherlands.",
  "city": "Amsterdam",
  "phone": "31 20 240 5250",
  "country": "Netherlands",
  "companyOfficers": [],
  "website": "http://www.kiadis.com",
  "maxAge": 1,
  "address1": "Paasheuvelweg 25A",
  "fax": "31 20 240 5251",
  "industry": "",
  "previousClose": 6.46979,
  "regularMarketOpen": 6.46979,
  "twoHundredDayAverage": 3.5965598,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 6.469791,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 6.46979,
  "fiftyDayAverage": 6.3081245,
  "trailingAnnualDividendRate": null,
  "open": 6.46979,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 4.928498,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 6.469791,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 10000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 190030704,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 8493,
  "priceToSalesTrailing12Months": null,
  "dayLow": 6.469791,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 10000,
  "fiftyTwoWeekHigh": 6.469791,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1.5,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 6.469791,
  "exchange": "PNK",
  "shortName": "KIADIS PHARMA NV",
  "longName": "Kiadis Pharma N.V.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "KIADF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_906608",
  "uuid": "d1e33654-34e5-35e4-ad49-8fbae353cada",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 20115100,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.30164,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.08676,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 35124394,
  "enterpriseValue": 259060432,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 6.46979,
  "logo_url": "https://logo.clearbit.com/kiadis.com"
}